Muutke küpsiste eelistusi

E-raamat: Renal Cancer: Contemporary Management

Edited by , Edited by
  • Formaat: EPUB+DRM
  • Ilmumisaeg: 16-Oct-2019
  • Kirjastus: Springer Nature Switzerland AG
  • Keel: eng
  • ISBN-13: 9783030243784
  • Formaat - EPUB+DRM
  • Hind: 122,88 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Formaat: EPUB+DRM
  • Ilmumisaeg: 16-Oct-2019
  • Kirjastus: Springer Nature Switzerland AG
  • Keel: eng
  • ISBN-13: 9783030243784

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

This book provides a state of the art overview of the major topics in the field of kidney cancer. The material has been collected from the most current evidence based resources to allow for the appropriate care of these patients.

This fully updated second edition provides a comprehensive, state of the art review of renal cancer, and will serve as a guide for urology residents, clinicians, surgeons, and researchers with an interest in renal cell carcinoma. The title reviews the latest information regarding epidemiology, clinical staging, molecular biology and genetics, hereditary syndromes, pathology, imaging, molecular imaging, interventional radiology, surgical advances, and the unified approach to surgery and systemic therapy of renal cell carcinoma. It also addresses the management of localized RCC, locally advanced disease, and advanced disease.

A valuable resource for physicians and researchers dealing with renal cancer, Renal Cancer: Contemporary Management, Second Edition provides a comprehensive summary of the field that will guide patient management and stimulate further clinical and basic science research efforts. 

Epidemiology, Screening, and Clinical Staging.- Molecular Biology and Genetics.- Familial and Hereditary Syndromes in Renal Cell Carcinoma.- Pathology of Renal Cell Cancer.- Imaging of Renal Cell Cancer.- Molecular Imaging for Renal Cell Carcinoma.- Interventional Radiology and Angioinfarction: Embolization of Renal Tumors.- Natural History, Role of Biopsy, and Active Surveillance of Renal Masses.- Rational for Partial Nephrectomy: Current Practice Patterns.- Objectifying Complexity of Kidney Cancer: Relationship of Tumor Anatomy and Outcomes.- History of Renal Surgery for Cancer.- The Surgical Approaches to Renal Masses and their Impact on Post-operative Renal Function.- Open Partial Nephrectomy.- Minimally Invasive Partial Nephrectomy and Ablative Procedures for Small Renal Masses.- Surgery for Renal Cell Carcinoma with Thrombus Extension into the Vena Cava.- Role of Lymphadenectomy in Renal Cell Cancer.- Role of Surgery in Locally Recurrent and Metastatic Renal Cancer.- Management of Non-Clear Renal Cell Carcinoma.- Surgical Management for Transitional Carcinoma of the Upper Tract.- Outcomes: Prognostic Factors, Models, and Algorithms.- Postoperative Surveillance Protocols for Renal Cell Carcinoma.- Role of Radiation Therapy in Renal Cancer.- Adjuvant Systemic Therapy, Immunotherapy and Targeted Treatment.- Unified Approached to Surgery and Systemic Therapy for Renal Cell Carcinoma.- Defining an Individualized Treatment Strategy for Metastatic Renal Cancer.
John Libertino M.D. Professor of UrologyTufts University School of Medicine Boston Massachusetts                 Jason Gee M.D.Associate Professor of UrologyTufts University School of MedicineBoston, Massachusetts